These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29108125)

  • 1. Robust fit of Bayesian mixed effects regression models with application to colony forming unit count in tuberculosis research.
    Burger DA; Schall R
    Stat Med; 2018 Feb; 37(4):544-556. PubMed ID: 29108125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust Bayesian nonlinear mixed-effects modeling of time to positivity in tuberculosis trials.
    Burger DA; Schall R; Chen DG
    Pharm Stat; 2018 Sep; 17(5):615-628. PubMed ID: 30027676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian Nonlinear Mixed-Effects Regression Model for the Characterization of Early Bactericidal Activity of Tuberculosis Drugs.
    Burger DA; Schall R
    J Biopharm Stat; 2015; 25(6):1247-71. PubMed ID: 25322214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A generalized Bayesian nonlinear mixed-effects regression model for zero-inflated longitudinal count data in tuberculosis trials.
    Burger DA; Schall R; Jacobs R; Chen DG
    Pharm Stat; 2019 Jul; 18(4):420-432. PubMed ID: 30957394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.
    de Knegt GJ; Dickinson L; Pertinez H; Evangelopoulos D; McHugh TD; Bakker-Woudenberg IAJM; Davies GR; de Steenwinkel JEM
    Tuberculosis (Edinb); 2017 Jul; 105():113-118. PubMed ID: 28610782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment mycobacterial sputum load influences individual on-treatment measurements.
    Diacon AH; van der Merwe L; Demers AM; Von Groote-Bidlingmaier F; Venter A; Donald PR
    Tuberculosis (Edinb); 2014 Dec; 94(6):690-4. PubMed ID: 25444765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A robust method for the assessment of average bioequivalence in the presence of outliers and skewness.
    Burger DA; Schall R; van der Merwe S
    Pharm Res; 2021 Oct; 38(10):1697-1709. PubMed ID: 34676489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens.
    Diacon AH; van der Merwe L; Demers AM; von Groote-Bidlingmaier F; Venter A; Donald PR
    Tuberculosis (Edinb); 2014 Mar; 94(2):148-51. PubMed ID: 24456754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlinear mixed-effects modeling of longitudinal count data: Bayesian inference about median counts based on the marginal zero-inflated discrete Weibull distribution.
    Burger DA; Lesaffre E
    Stat Med; 2021 Oct; 40(23):5078-5095. PubMed ID: 34155664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reiterative method for calculating the early bactericidal activity of antituberculosis drugs.
    Gillespie SH; Gosling RD; Charalambous BM
    Am J Respir Crit Care Med; 2002 Jul; 166(1):31-5. PubMed ID: 12091167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust Bayesian mixed effects approach for zero inflated and highly skewed longitudinal count data emanating from the zero inflated discrete Weibull distribution.
    Burger DA; Schall R; Ferreira JT; Chen DG
    Stat Med; 2020 Apr; 39(9):1275-1291. PubMed ID: 32092193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian quantile regression for nonlinear mixed-effects joint models for longitudinal data in the presence of mismeasured covariate errors.
    Huang Y; Chen J; Qiu H
    J Biopharm Stat; 2017; 27(5):741-755. PubMed ID: 27936356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skew-normal Bayesian nonlinear mixed-effects models with application to AIDS studies.
    Huang Y; Dagne G
    Stat Med; 2010 Oct; 29(23):2384-98. PubMed ID: 20603815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.
    Deshpande D; Srivastava S; Nuermberger E; Pasipanodya JG; Swaminathan S; Gumbo T
    Clin Infect Dis; 2016 Nov; 63(suppl 3):S95-S101. PubMed ID: 27742640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimising moxifloxacin resistance with tuberculosis.
    Drlica K; Zhao X; Kreiswirth B
    Lancet Infect Dis; 2008 May; 8(5):273-5. PubMed ID: 18471768
    [No Abstract]   [Full Text] [Related]  

  • 16. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis.
    Hu Y; Coates AR; Mitchison DA
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.
    Adrion C; Mansmann U
    BMC Med Res Methodol; 2012 Sep; 12():137. PubMed ID: 22962944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.
    Gumbo T; Louie A; Liu W; Brown D; Ambrose PG; Bhavnani SM; Drusano GL
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2329-36. PubMed ID: 17438043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian analysis for nonlinear regression model under skewed errors, with application in growth curves.
    De la Cruz R; Branco MD
    Biom J; 2009 Aug; 51(4):588-609. PubMed ID: 19629998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
    Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA
    Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.